Dr. Papenfuss is a fellowship-trained surgical oncologist who treats cancers of the pancreas, liver, bile ducts, stomach and esophagus, as well as sarcoma and cancers that have spread to the lining of the abdomen. He practices at Advocate Health St. Luke's Medical Center in Milwaukee, a high-volume referral center for complex hepatobiliary disease.
He completed fellowship training in Complex General Surgical Oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York, and is board certified by the American Board of Surgery in both Complex General Surgical Oncology and General Surgery. He is a Fellow of the American College of Surgeons (FACS) and a Fellow of the Society of Surgical Oncology (FSSO).
Leadership roles include Chief of Surgery at St. Luke's Medical Center, Medical Director of Surgical Oncology, Program Director of the Complex General Surgical Oncology Fellowship, and cancer service line leader for Advocate Health. He co-founded the St. Luke's HIPEC program in 2018, which now performs more than 40 procedures a year.
His clinical focus is hepatopancreaticobiliary (HPB) cancer. He is a high-volume robotic surgeon who performs the Whipple operation, distal pancreatectomy, liver resection, gastrectomy and esophagectomy using minimally invasive techniques, and he serves as a robotic surgery proctor for Intuitive Surgical. In 2026 he began offering histotripsy, a non-invasive focused-ultrasound treatment for liver tumors, as part of a combined HPB program with Advocate Health's transplant surgeons. Every liver patient is reviewed at a joint conference of surgical oncologists, transplant surgeons, hepatologists, medical and radiation oncologists, and interventional radiologists.
Dr. Papenfuss maintains an active research program in robotic cancer surgery outcomes and bile duct cancer. To schedule a consultation or second opinion, call 414-649-3240.

Buffalo, New York
Formed in 1898 by Dr. Roswell Park, RPCI was the nation's first dedicated cancer institute. RPCI set the standard for the multidisciplinary approach to cancer. RPCI is one of only a handful of training programs in the US and Canada that are accredited by the Society of Surgical Oncology and the Accreditation Council for Graduate Medical Education making graduates eligible for Board Certification in Complex General Surgical Oncology.
Dr. Papenfuss completed his surgical oncology fellowship at RPCI and graduated as Chief Administrative Fellow in 2014. He became Board Certified in Complex General Surgical Oncology in 2015 after completing rigorous written and oral exams administered by the American Board of Surgery.
Dr. Papenfuss completed his general surgery residency at Iowa Health System in Des Moines, Iowa, before pursuing fellowship training in surgical oncology.
Dr. Papenfuss earned his medical degree at the University of North Dakota School of Medicine and Health Sciences in Grand Forks, North Dakota.
This is a personally maintained website. Advocate Health is not responsible for its content. Information on this site is general and is not medical advice for any individual patient.